Skip to main content
Caplight Logo









Palo Santo

Palo Santo

Chicago, Illinoispalosanto.com

Overview

Palo Santo is a venture capital fund focused on emerging psychedelic medicines and therapies poised to address the growing mental health crisis and creating a new paradigm in wellbeing . The fund targets a diverse range of companies offering innovative solutions across biopharma, drug development, digital therapeutics, healthcare services and tech-enabled solutions to address the growing global mental health crisis . From cutting-edge science to commercial application, Palo Santo's portfolio includes 20+ companies focused on advancing the field of psychedelic medicines and expanding patient access and affordability .

Year Founded

2020

AUM

$50M

Portfolio Companies

7

Investments

Palo Santo investments
CompanyDateStageLead
Delix TherapeuticsSep 2021Series A-
Sensorium TherapeuticsNov 2022Series ACo-investor
Xylo BioJun 2024SeedCo-investor
Gwella MushroomsJun 2021SeedCo-investor
FluenceFeb 2022SeedLead
Book a demo to see all investments

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Book a demo to explore sector, stage, and valuation breakdowns for this investor.

Book a demo

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Book a demo to explore yearly investment trends and funding raised over time.

Book a demo

For institutional investors. Book with your work email.

FAQ

Where is Palo Santo based?

Palo Santo is headquartered in Chicago, Illinois, United States.

When was Palo Santo founded?

Palo Santo was founded in 2020.

How many portfolio companies does Palo Santo have?

Palo Santo has 7 portfolio companies in Caplight's dataset.

What are some companies in Palo Santo's portfolio?

Portfolio companies visible on Caplight include Delix Therapeutics, Sensorium Therapeutics, Xylo Bio, Gwella Mushrooms, Fluence.

What was Palo Santo's most recent investment shown here?

Palo Santo's most recent investment in this portfolio sample was in Xylo Bio in 2024.

What sectors does Palo Santo focus on?

Palo Santo focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech, Healthcare & Life Sciences.

What company stages does Palo Santo focus on?

Palo Santo typically invests at the Early stage.

What is Palo Santo's AUM?

Palo Santo's assets under management are estimated between $50.0M and $100.0M.

Firmographic Details

HeadquartersChicago, Illinois
Year Founded2020
AUM$50M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?